Recently, direct inhibition of factor Xa (FXa), which links the intrinsic and extrinsic mechanisms in the blood coagulation cascade, [3] [4] [5] [6] [7] has emerged as an attractive strategy for the discovery of novel antithrombotic agents. [8] [9] [10] [11] In previous papers, 1,2) we reported the synthesis and biological activity of new compounds in a series of 1-arylsulfonyl-3-piperazinone derivatives, and through this investigation M55113 (1) (IC 50 : 0.06 mM) and M55551 (2) (IC 50 : 0.006 mM) were confirmed to be somewhat favorable as FXa inhibitors.
of glycine (10) with sulfonyl chloride 5 under basic conditions, was treated with 1-(4-pyridinyl)-4-aminomethylpiperidine (12) , which was obtained by Mitsunobu reaction of the corresponding methanol, in the presence of N,NЈ-dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole hydrate (HOBt) to yield the amide 13.
Synthesis of (R)-3-aminoalanine derivative 19 was accomplished according to the route shown in Chart 3. Sulfonylation of ethyl ester 15 derived from (R)-3-amino-2-(benzyloxycarbonylamino)propionic acid (14) with sulfonyl chloride 5 in CH 2 Cl 2 in the presence of Et 3 N resulted in smooth formation of the sulfonamide 16. Deprotection of 16 with trimethylsilyl iodide (TMSI) in MeCN followed by reductive condensation with 8 afforded compound 18. Hydrolysis of 18 in hydrochloric acid and acetic acid yielded the desired 3-aminoalanine derivative 19. Starting from (S)-3-amino-2-(benzyloxycarbonylamino)propionic acid, the method used to synthesize compound 19 was repeated to obtain compound 20. Throughout the synthesis described above, no racemization was observed.
Results and Discussion
The FXa inhibitory activities of these compounds were measured by a method similar to that described in the preceding paper, 1, 2) and are listed in the Table 1 as IC 50 values. The following conclusions are derived from these data, though they are still provisional.
First, compared with the activity of compound 1 (M55113), those of compounds 9 and 13 are quite low. Similarly, the activity of compound 19 was shown to be 1/100 that of compound 2 (M55551). A similar difference in activity was observed between 3 and 20. These data suggest that rigidity of the central part of the molecules tested in this series may be an important factor for significantly FXa inhibitory activity.
Second, when a carbonyl group or a carboxyl group was introduced into the ethylenediamine skeleton (13, 19), activity clearly increased with activities of 13 and 19 four and five times that of 9, respectively. These findings suggest that carbonyl and carboxyl groups favor interaction with FXa protein.
Finally, regarding the stereochemistry of carboxylic substitution, it is clear that (R)-isomers have higher activity than (S)-isomers in both the piperazine 2 and ethylenediamine 19 skeleton.
These findings may be useful in guiding molecular design in this field.
Experimental
Melting points (mp) were determined by using METTLER FP82 hotstage melting point apparatus and were uncorrected. Nuclear magnetic resonance (NMR) spectra were taken with JEOL JNM-EX270 FT-NMR or JEOL JNM- 
Measurement of Factor Xa Inhibition
The enzyme solution was mixed with a test compound dissolved at various concentrations in dimethyl sulfoxide (DMSO). Synthetic substrate was added and incubated in a 20 mM Tris-HCl buffer (pH 7.5) containing 0.13 M NaCl at 37°C. The absorbance at 405 nm was measured continuously. The following enzyme and substrate were used: human factor Xa (Enzyme Research Laboratories, Inc., 0.019 U/ml) and S-2222 (Chromogenix AB, 0.4 mM). To calculate the inhibitory activity of the test compound, the initial reaction velocity was compared with the value for a control containing no test compound. The inhibitory activity of a test compound was expressed as IC 50 .
N-(2-tert-Butoxycarbonylaminoethyl)-6-chloro-2-naphthalenesulfonamide (6) To a solution of N-(tert-butoxycarbonyl)ethylenediamine hydrochloride (4) (310 mg, 1.92 mmol) in dry CH 2 Cl 2 (15 ml), 6-chloro-2-naphthalenesulfonyl chloride (5) (500 mg, 1.92 mmol) and Et 3 N (0.27 ml, 2.30 mmol) were added and the mixture was stirred overnight at room temperature. Water (30 ml) was added to the reaction mixture and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine and dried over dry Na 2 N-(2-Aminoethyl)-6-chloro-2-naphthalenesulfonamide (7) Anisole (0.49 ml) and TFA (3.8 ml) were added to compound 6 (0.75 g, 1.95 mmol) at cooling with ice bath and the mixture was stirred for 2 h at room temperature. Et 2 O (5 ml) was added to the reaction mixture. After vigorous stirring and followed standing, the supernatant was removed by decantation and another 5 ml portion of Et 2 O was added. This procedure was repeated three times. The residue was crystallized from CH 2 .70 mmol) in dry CH 2 Cl 2 (3 ml) containing AcOH (0.07 ml) was stirred at room temperature for 30 min under Ar. To the solution, NaBH(OAc) 3 (298 mg, 1.4 mmol) was added and the mixture was stirred overnight at room temperature. Water (5 ml) was added to the reaction mixture, which was adjusted to pH 9 with 1 N NaOH and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine and dried over dry Na 2 N-[(6-Chloro-2-naphthalenyl)sulfonyl]glycine (11) To a solution of glycine (10) (276 mg, 3.68 mmol) and K 2 CO 3 (508 mg, 3.68 mmol) in H 2 O (8 ml), 6-chloro-2-naphthalenesulfonyl chloride (5) (800 mg, 3.06 mmol) and PhMe (1.0 ml) were added and the mixture was refluxed for 90 min. The reaction mixture was adjusted to pH 1 with 3 N HCl and the mixture was extracted with EtOAc. The organic layer was washed with water and brine and dried over dry Na 2 SO 4 . The solvent was evaporated under reduced pressure to yield compound 11 (820 mg, 89%) as colorless powder, mp 174-176°C. 1 -H of piperidine). 
Ethyl (R)-2-(Benzyloxycarbonyl)amino-3-[(6-chloro-2-naphthalenylsulfonyl)amino]propionate (16)
To a solution of 6-chloro-2-naphthalenesulfonyl chloride (5) (52.5 g, 0.20 mol) in dry CH 2 Cl 2 (1130 ml), compound 15 (60.9 g, 0.20 mmol) and Et 3 N (56.1 ml, 0.4 mol) were added and the mixture was stirred at room temperature for three days under Ar. Water (700 ml) was added to the reaction mixture and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine and dried over dry Na 2 2.63 g, 14 mmol ) and compound 17 (5.0 g, 14 mmol) in dry CH 2 Cl 2 (117 ml) containing AcOH (1.67 ml) were stirred at room temperature for 50 min under Ar. To the reaction mixture, NaBH(OAc) 3 (7.42 g, 35 mmol) was added and the mixture was stirred overnight at room temperature. Water (200 ml) was added to the reaction mixture, which was adjusted to pH 7 by sat. aq. NaHCO 3 and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine and dried over dry Na 2 
